The effects of globalisation on the pharmaceutical industry in emerging markets: the case of Turkey
by M. Cagri Pehlivanoglu
International Journal of Trade and Global Markets (IJTGM), Vol. 3, No. 3, 2010

Abstract: Foreign Direct Investment (FDI) has become the most important determinant in the process of globalisation, and as such, it is changing the economies of many countries. The main objective of this research is to investigate the nature of FDI inflows into the Turkish pharmaceutical industry and examine whether local or multinational firms drive the changing market. The paper indicates that when considering FDI, potential benefits must be weighed against potential costs. It is recommended that countries be cautious about maintaining local producers while involving multinationals in their industries.

Online publication date: Thu, 26-Aug-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Trade and Global Markets (IJTGM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com